Sales rise 5.39% to Rs 18.37 crore
Net profit of Sandu Pharmaceuticals rose 166.67% to Rs 0.56 crore in the quarter ended December 2024 as against Rs 0.21 crore during the previous quarter ended December 2023. Sales rose 5.39% to Rs 18.37 crore in the quarter ended December 2024 as against Rs 17.43 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var.Sales18.3717.43 5 OPM %5.442.93 -PBDT0.990.52 90 PBT0.800.38 111 NP0.560.21 167Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
